MetabolicSEMAGLUTIDE
10MG
$90
Description
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics the incretin hormone GLP-1 to regulate appetite, blood sugar, and metabolic function. It works by binding to GLP-1 receptors in the pancreas (stimulating insulin release and suppressing glucagon), the gut (slowing gastric emptying), and the brain (reducing appetite and food cravings through hypothalamic signaling). Semaglutide has a modified structure with a fatty acid side chain that enables binding to albumin, extending its half-life to approximately 7 days. It is one of the most extensively studied metabolic peptides, with FDA approval under multiple brand names.
Potential Benefits
Research Notes
Semaglutide is backed by some of the largest clinical trial programs in metabolic research. The STEP trials (published in NEJM) demonstrated average weight reductions of 14.9-16.9% over 68 weeks. The SELECT cardiovascular outcomes trial showed a 20% reduction in major adverse cardiovascular events. Semaglutide research spans obesity, type 2 diabetes, NASH, and cardiovascular protection, with ongoing trials exploring additional applications.
Usage Information
For research and educational purposes only. Consult with a qualified professional before use.
All peptides must be refrigerated upon receipt.
RESEARCH PURPOSES ONLY
This product is intended for research and educational purposes only. Not intended for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.